Qiagen will develop assays for Lilly's drugs

02/14/2013 | GenomeWeb Daily News (free registration)

Qiagen agreed to develop companion diagnostic tests for Eli Lilly & Co.'s experimental and approved drugs. The alliance expands Lilly's "capabilities to more quickly and cost-effectively bring innovative new medicines, alongside advanced diagnostics, to patients worldwide who are waiting," said Daniel Skovronsky, Lilly's vice president of tailored therapeutics.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA